Prophylaxis in Aplastic Anemia Based on Absolute Neutrophil Count

Risk Assessment and Prophylaxis

The National Comprehensive Cancer Network recommends that antimicrobial prophylaxis should be initiated in patients with aplastic anemia when the absolute neutrophil count (ANC) is less than 500/mm³, as these patients are at substantial risk for invasive infections, particularly aspergillosis 1, 2
Patients with aplastic anemia and ANC < 500/mm³ are at high risk for life-threatening infections and should receive prophylaxis 1
The risk of infection significantly increases with the duration of neutropenia, particularly when ANC < 500/mm³ persists for more than 7 days 3

The National Comprehensive Cancer Network recommends mold-active antifungal prophylaxis (e.g., posaconazole or voriconazole) for patients with ANC < 500/mm³ 1
Antiviral prophylaxis is recommended for HSV-seropositive patients during periods of neutropenia 1
Consider fluoroquinolone prophylaxis for patients with ANC < 500/mm³ expected to last > 7 days 3, 2

Secondary prophylaxis with appropriate antifungal agents should be administered to patients with prior invasive fungal infections 1
Patients with chronic severe neutropenia due to aplastic anemia are at substantial risk for invasive aspergillosis 1
Discontinuing prophylaxis prematurely before adequate neutrophil recovery should be avoided 1
Neglecting to monitor for antimicrobial resistance when using prophylactic antibiotics should be avoided 2

For patients with low absolute neutrophil count (ANC), prophylactic acyclovir should be dosed at 200 mg orally every 12 hours when ANC is <500/mm³, with dose adjustment to 200 mg three times daily for standard prophylaxis when ANC recovers above this threshold, as recommended by the Centers for Disease Control and Prevention (CDC) 4
The standard prophylactic dosing of acyclovir is 200 mg orally three times daily, or 400 mg orally every 12 hours, when ANC is >500/mm³, according to the CDC guidelines 4
Do not use standard prophylactic doses (200 mg TID or 400 mg BID) without considering dose reduction when ANC is severely depressed, as this may worsen neutropenia, as advised by the CDC 4